Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up

Lucas N L Van Aelst; Marjorie Abraham; Malha Sadoune; Thibaud Lefebvre; Philippe Manivet; Damien Logeart; Jean-Marie Launay; Zoubida Karim; Hervé Puy; Alain Cohen-Solal

doi:10.1002/ejhf.837

Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up

Eur J Heart Fail. 2017 Aug;19(8):1075-1076. doi: 10.1002/ejhf.837. Epub 2017 May 17.

Authors

Lucas N L Van Aelst¹, Marjorie Abraham^{2

3}, Malha Sadoune³, Thibaud Lefebvre^{4

5}, Philippe Manivet^{3

6

7}, Damien Logeart^{2

3

8}, Jean-Marie Launay^{3

6

7}, Zoubida Karim^{4

5}, Hervé Puy^{4

5}, Alain Cohen-Solal^{2

3

8}

Affiliations

¹ Department of Cardiovascular Sciences, Catholic University of Leuven, Leuven, Belgium.
² Department of Cardiology, Lariboisière Hospital, Paris, France.
³ U942 INSERM BIOCANVAS (Biomarqueurs Cardiovasculaires), Paris, France.
⁴ INSERM U1149, Centre de Recherche sur l'Inflammation, University of Paris VII Denis Diderot, Paris, France.
⁵ Laboratory of Excellence, GR-Ex Imagine Institute, Paris, France.
⁶ Medical Biochemistry and Molecular Biology, Lariboisière Hospital, Paris, France.
⁷ Biossip Analytical Platform, Centre for Biological Resources BB-0033-00064, Lariboisière Hospital, Paris, France.
⁸ Department of Cardiology, University of Paris VII Denis Diderot, Paris, France.

PMID: 28516737
DOI: 10.1002/ejhf.837

No abstract available

Keywords: Heart failure; biomarkers; ferritin; hepcidin; iron deficiency; treatment.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Aged
Biomarkers / blood
Female
Ferritins / blood
Follow-Up Studies
Heart Failure / blood*
Heart Failure / physiopathology
Humans
Inpatients*
Iron / blood*
Male
Time Factors

Substances

Biomarkers
Ferritins
Iron

Associated data

ClinicalTrials.gov/NCT01374880